Dr. Henry Merritt, DPM

NPI: 1184689119
Total Payments
$1,744
2024 Payments
$244.32
Companies
12
Transactions
28
Medicare Patients
569
Medicare Billing
$113,777

Payment Breakdown by Category

Food & Beverage$1,744 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,744 28 100.0%

Top Paying Companies

Company Total Records Latest Year
Paratek Pharmaceuticals, Inc. $384.73 14 $0 (2024)
Horizon Pharma plc $339.69 3 $0 (2018)
Horizon Therapeutics plc $215.53 2 $0 (2021)
Stryker Corporation $137.07 1 $0 (2017)
KCI USA, Inc $108.16 1 $0 (2018)
Cook Medical LLC $104.49 1 $0 (2019)
Smith & Nephew, Inc. $99.29 1 $0 (2017)
Nevro Corp. $97.27 1 $0 (2023)
Cardiovascular Systems Inc. $97.22 1 $0 (2017)
Heron Therapeutics, Inc. $72.47 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $244.32 8 Paratek Pharmaceuticals, Inc. ($244.32)
2023 $301.94 8 Paratek Pharmaceuticals, Inc. ($140.41)
2022 $72.47 1 Heron Therapeutics, Inc. ($72.47)
2021 $129.41 2 Horizon Therapeutics plc ($105.81)
2019 $214.21 2 Horizon Therapeutics plc ($109.72)
2018 $200.91 2 KCI USA, Inc ($108.16)
2017 $580.52 5 Horizon Pharma plc ($246.94)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/09/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $5.00 General
Category: ANTIBIOTIC
10/18/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $9.84 General
Category: ANTIBIOTIC
08/29/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $9.53 General
Category: ANTIBIOTIC
08/21/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $101.73 General
Category: ANTIBIOTIC
07/30/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $4.58 General
Category: ANTIBIOTIC
04/18/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $6.83 General
Category: ANTIBIOTIC
02/22/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $5.21 General
Category: ANTIBIOTIC
02/13/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $101.60 General
Category: ANTIBIOTIC
12/07/2023 ETS Wound Care LLC Food and Beverage Cash or cash equivalent $64.26 General
11/09/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $2.24 General
Category: ANTIBIOTIC
09/28/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $5.24 General
Category: ANTIBIOTIC
06/02/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $3.19 General
Category: ANTIBIOTIC
04/28/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $2.75 General
Category: ANTIBIOTIC
04/05/2023 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $97.27 General
Category: Spinal Cord Stimulator
03/07/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: ANTIBIOTIC
02/09/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $1.99 General
Category: ANTIBIOTIC
07/29/2022 Heron Therapeutics, Inc. Zynrelef (Drug) Food and Beverage In-kind items and services $72.47 General
Category: Postoperative Pain
12/07/2021 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $105.81 General
Category: KRYSTEXXA
11/11/2021 Philips Electronics North America Corporation (6575) Coronary Undivided (Device) Food and Beverage Cash or cash equivalent $23.60 General
Category: Medical Device
08/01/2019 Cook Medical LLC Cook Medical Zilver PTX (Device) Food and Beverage Cash or cash equivalent $104.49 General
Category: Peripheral Intervention
01/30/2019 Horizon Therapeutics plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage Cash or cash equivalent $109.72 General
Category: RAYOS
06/29/2018 Horizon Pharma plc KRYSTEXXA (Drug) Food and Beverage Cash or cash equivalent $92.75 General
Category: KRYSTEXXA
06/14/2018 KCI USA, Inc SNAP (Device) Food and Beverage In-kind items and services $108.16 General
Category: TRAUMA EMERGENCY, INJURY, SURGERY
10/17/2017 Cardiovascular Systems Inc. Peripheral Orbital Atherectomy System (Device) Food and Beverage Cash or cash equivalent $97.22 General
Category: Atherectomy Device
08/23/2017 Horizon Pharma plc KRYSTEXXA (Drug) Food and Beverage Cash or cash equivalent $121.95 General
Category: KRYSTEXXA

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 155 453 $45,105 $32,013
2022 4 129 399 $38,940 $27,369
2021 4 146 427 $40,835 $29,413
2020 4 139 433 $34,284 $24,982
Total Patients
569
Total Services
1,712
Medicare Billing
$113,777
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 118 394 $39,400 $28,765 73.0%
17110 Destruction of skin growth, 1-14 growths Office 2023 12 21 $2,625 $1,933 73.6%
20550 Injection into tendon or ligament Office 2023 12 20 $2,000 $962.20 48.1%
73620 X-ray of foot, 2 views Office 2023 13 18 $1,080 $352.98 32.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 79 329 $32,900 $24,477 74.4%
20550 Injection into tendon or ligament Office 2022 11 25 $2,500 $1,220 48.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $1,560 $1,030 66.0%
73620 X-ray of foot, 2 views Office 2022 27 33 $1,980 $642.68 32.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 92 343 $34,280 $25,952 75.7%
20600 Aspiration and/or injection of small joint or joint capsule Office 2021 12 31 $2,325 $1,361 58.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 15 15 $1,950 $1,325 68.0%
73620 X-ray of foot, 2 views Office 2021 27 38 $2,280 $774.88 34.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 92 359 $28,704 $22,037 76.8%
20600 Aspiration and/or injection of small joint or joint capsule Office 2020 15 32 $2,400 $1,355 56.5%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 11 11 $1,320 $980.07 74.2%
73620 X-ray of foot, 2 views Office 2020 21 31 $1,860 $609.40 32.8%

About Dr. Henry Merritt, DPM

Dr. Henry Merritt, DPM is a Podiatrist healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184689119.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Merritt, DPM has received a total of $1,744 in payments from pharmaceutical and medical device companies, with $244.32 received in 2024. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,744).

As a Medicare-enrolled provider, Merritt has provided services to 569 Medicare beneficiaries, totaling 1,712 services with total Medicare billing of $113,777. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Podiatrist
  • Location Lauderhill, FL
  • Active Since 04/20/2006
  • Last Updated 11/07/2011
  • Taxonomy Code 213E00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1184689119

Products in Payments

  • NUZYRA (Drug) $384.73
  • RAYOS (Drug) $234.71
  • KRYSTEXXA (Drug) $214.70
  • Variax (Device) $137.07
  • SNAP (Device) $108.16
  • KRYSTEXXA (Biological) $105.81
  • Cook Medical Zilver PTX (Device) $104.49
  • Santyl (Drug) $99.29
  • Senza (Device) $97.27
  • Peripheral Orbital Atherectomy System (Device) $97.22
  • Zynrelef (Drug) $72.47
  • (6575) Coronary Undivided (Device) $23.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.